Abbott Laboratories
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $39.39B | $75.20B | $9.80B |
| FY2022 | $37.75B | $74.44B | $9.88B |
| FY2023 | $34.61B | $73.21B | $6.90B |
| FY2024 | $33.75B | $81.41B | $7.62B |
| FY2025 | $34.58B | $86.71B | $8.52B |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $39.39B | $75.20B | $9.80B |
| FY2022 | $37.75B | $74.44B | $9.88B |
| FY2023 | $34.61B | $73.21B | $6.90B |
| FY2024 | $33.75B | $81.41B | $7.62B |
| FY2025 | $34.58B | $86.71B | $8.52B |